Trial intelligence / Profile preview

Phase II alectinib in pretreated RET-rearranged advanced NSCLC

2017-002063-17Phase 2Active

Sponsor

ETOP IBCSG Partners Foundation

Start

Dec 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1